BOC.04.2: TWO-YEAR EFFICACY AND SAFETY OF MIRIKIZUMAB FOLLOWING 104 WEEKS OF CONTINUOUS TREATMENT: INTERIM RESULTS FROM THE LUCENT-3 OPEN-LABEL EXTENSION STUDY
Titel:
BOC.04.2: TWO-YEAR EFFICACY AND SAFETY OF MIRIKIZUMAB FOLLOWING 104 WEEKS OF CONTINUOUS TREATMENT: INTERIM RESULTS FROM THE LUCENT-3 OPEN-LABEL EXTENSION STUDY
Auteur:
Sands, B.E. D'haens, G. Clemow, D.B. Irving, P.M. Johns, J.T. Hunter Gibble, T. Abreu, M.T. Lee, S. Hisamatsu, T. Kobayashi, T. Dubinsky, M.C. Vermeire, S. Siegel, C.A. Peyrin-Biroulet, L. Moses, R.E. Milata, J. Arora, V. Panaccione, R. Dignass, A. Monteleone, G.
Verschenen in:
Digestive and liver disease
Paginering:
Jaargang 56 () nr. S2 pagina's S121-S122
Jaar:
2024
Inhoud:
Uitgever:
Editrice Gastroenterologica Italiana S.r.l. All rights reserved.